Mapping large numbers of results may take a few moments.
Search Results
Showing 51 - 100 of 328 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company BioAgilytix Labs LLC | Activity: Contract Research and Testing | Company Description BioAgilytix is a global contract research organization and provides PK, immunogenicity, biomarkers, and cell-based assays supporting the development and release testing of therapeutics across all stages of drug development. | Location Durham |
| |
Company Biocomposites Inc. | Activity: Sales and Operations | Company Description Biocomposites develops, manufactures and distributes calcium compound devices to regenerate and repair bone and soft tissue for use in musculoskeletal infections, trauma, spine and sports injuries. The Wilmington office is a sales office. | Location Wilmington |
| |
Company BioCryst Pharmaceuticals Inc. | Activity: Research and Development | Company Description BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams. | Location Durham |
| |
Company BioCytics Inc. | Activity: Research and Development | Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is co-located with its sister company, the Carolina BioOncology Institute. | Location Huntersville |
| |
Company Biogen | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. The Drug Substance Campus in RTP is home to biologics production and a patient services contact center. | Location Research Triangle Park |
| |
Company Biogen (Oral Solid Dose Facility) | Activity: Production and Manufacturing | Company Description Biogen discovers, develops and manufactures therapies for serious neurological diseases. This site houses oral solid dose and anti-sense oligonucleotide production, packaging and fill/finish operations, as well as a Global Business Services center. | Location Research Triangle Park |
| |
Company BioKier Inc. | Activity: Research and Development | Company Description BioKier develops proprietary adjuvant treatments for diabetes and related disorders. BioKier has identified a therapeutic opportunity based on gastric bypass surgery and is developing several novel treatments for cardiometabolic diseases including hyperlipidemia and insulin resistance. | Location Chapel Hill |
| |
Company BioLink Life Sciences Inc. | Activity: Contract Research and Testing | Company Description BioLink provides contract product development support through custom synthesis and testing for the pharmaceutical, nutraceuticals, animal health and chemical industries. | Location Cary |
| |
Company Bionpharma Inc. | Activity: Sales and Operations | Company Description Bionpharma partners with pharmaceutical companies to in-license, out-license, develop, manufacture and distribute generic and over-the-counter products. Its Raleigh location is a sales office. | Location Morrisville |
| |
Company Black Swan Pharmaceuticals Inc. | Activity: Research and Development | Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. | Location Wake Forest |
| |
Company Blue Ridge Institute for Medical Research | Activity: Research and Development | Company Description Blue Ridge Institute for Medical Research (BRIMR) researches small-molecule inhibitors of protein kinases and targeted cancer therapies. BRIMR also generates an annual ranking of NIH funding for U.S. medical schools and their departments. | Location Hendersonville |
| |
Company BMI OrganBank | Activity: Research and Development | Company Description BMI OrganBank develops products for ex vivo perfusion and preservation of organs and tissue. | Location Denver |
| |
Company BridgeBio Gene Therapy | Activity: Research and Development | Company Description BridgeBio Gene Therapy is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. | Location Raleigh |
| |
Company Brii Biosciences Inc. | Activity: Research and Development | Company Description Brii Biosciences develops therapies focused on infectious diseases and central nervous system diseases where patients experience high levels of unmet medical needs, limited choice and significant social stigmas. | Location Durham |
| |
Company Bryn Pharma LLC | Activity: Research and Development | Company Description Bryn Pharma is developing a nasal solution for the administration of emergency epinephrine for the treatment of anaphylaxis. | Location Raleigh |
| |
Company Caeregen Therapeutics LLC | Activity: Research and Development | Company Description Caeregen Therapeutics develops therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Caeregen is developing Noregen, a recombinant protein mimetic of human norrin-derived growth factor for the potential treatment of retinal-related vision loss. | Location Chapel Hill |
| |
Company Cambrex Durham | Activity: Contract Research and Testing | Company Description Cambrex offers development, analytical services and manufacturing of APIs and small molecule drugs. Its Durham site provides drug substance development and manufacturing, as well as analytical services and microbiology testing services. | Location Durham |
| |
Company Cambrex High Point | Activity: Production and Manufacturing | Company Description Cambrex High Point develops and manufactures small-molecule APIs and intermediates for Phase I through III clinical trials. It offers custom organic synthesis, process development, analytical development and cGMP manufacturing services. | Location High Point |
| |
Company Campbell University Pharmaceutical Education and Research Center (PERC) | Activity: Contract Research and Testing | Company Description The Pharmaceutical Education & Research Center (PERC) offers analytical, formulation, R&D, clinical manufacturing and training services to the pharma and biotech industries, compounding pharmacies, government agencies and other academic institutions. | Location Buies Creek |
| |
Company Cancer Advances Inc. | Activity: Research and Development | Company Description Cancer Advances, a subsidiary of Cato Bioventures, develops immunomodulator therapeutics to treat gastrointestinal cancers. | Location Durham |
| |
Company CardioPharma Inc. | Activity: Research and Development | Company Description CardioPharma develops combinatorial products to treat cardiovascular disease. | Location Wilmington |
| |
Company CARsgen Therapeutics | Activity: Production and Manufacturing | Company Description CARsgen Therapeutics develops innovative CAR-T cell therapies for the treatment of hematological malignancies and solid tumors. | Location Durham |
| |
Company Catalent Pharma Solutions LLC (Greenville) | Activity: Production and Manufacturing | Company Description Catalent Pharma Solutions manufactures oral solid dosage forms, including integrated formulation development, analytical services, commercial manufacturing, and packaging. | Location Greenville |
| |
Company Catalent Pharma Solutions LLC (Morrisville) | Activity: Contract Research and Testing | Company Description Catalent provides drug development and manufacturing services for the pharma, biotech and consumer sectors. Core offerings include biologics, parenterals, oral solids, softgel, inhalation, clinical supply services and analytical services. | Location Morrisville |
| |
Company Cellectis | Activity: Production and Manufacturing | Company Description Cellectis develops gene-editing technologies and cell therapies to treat cancers of the blood, myeloid, and lymphatic systems. The Raleigh location is the company's GMP manufacturing plant for Cellectis' portfolio of UCART drug products. | Location Raleigh |
| |
Company Cellective BioTherapy Inc. | Activity: Research and Development | Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. | Location Chapel Hill |
| |
Company Cessation Therapeutics | Activity: Sales and Operations | Company Description Cessation Therapeutics is developing novel antibody therapies to prevent and reverse overdose related to fentanyl and related synthetic opioids. The Chapel Hill site is Cessation's corporate office. | Location Chapel Hill |
| |
Company Chiesi USA Inc. | Activity: Research and Development | Company Description Chiesi USA, the U.S. affiliate of Chiesi Farmaceutici S.p.A, develops and commercializes products in the therapeutic areas of rare disease, respiratory, cardiovascular, neonatology and cystic fibrosis. | Location Cary |
| |
Company Chimerix Inc. | Activity: Research and Development | Company Description Chimerix discovers, develops and commercializes broad spectrum antivirals for the prevention and treatment of life-threatening viral infections. | Location Durham |
| |
Company Citranvi Biosciences LLC | Activity: Research and Development | Company Description Citranvi develops vaccine technology platforms and products, using comprehensive structure-based vaccine design, broadly applicable to a variety of viral pathogens such as Cytomegalovirus, Epstein-Barr Virus and Coronaviruses. | Location Chapel Hill |
| |
Company Claradele Pharmaceuticals Inc. | Activity: Research and Development | Company Description Claradele Pharmaceuticals is developing an immunotherapy product to treat melanoma. | Location Winterville |
| |
Company Clarus Biologics Inc. | Activity: Research and Development | Company Description Clarus Biologics is developing innovative vaccine and immunotherapeutic products using a novel and proprietary self-amplifying mRNA delivery and viral particle technology platform. Its first innovation is a vaccine VLP that enhances the effectiveness, efficiency and availability of vaccines. | Location Chapel Hill |
| |
Company Cloud Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases. | Location Research Triangle Park |
| |
Company CMP Pharma Inc. | Activity: Production and Manufacturing | Company Description CMP develops, manufactures and commercializes niche oral liquid medications that address the needs of patients with difficulty swallowing solid dosage forms. | Location Farmville |
| |
Company CogniKey Pharma LLC | Activity: Contract Research and Testing | Company Description CogniKey Pharma develops drugs to treat cognitive impairment in CNS disorders. CogniKey has a special interest in the treatment of Mild Cognitive Impairment (MCI). | Location Winston-Salem |
| |
Company Cognosci Inc. | Activity: Research and Development | Company Description Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications. | Location Durham |
| |
Company Collaborations Pharmaceuticals Inc. | Activity: Contract Research and Testing | Company Description Collaborations Pharmaceuticals develops drugs for rare and neglected diseases using machine learning software, providing preclinical and clinical expertise to rare disease foundations, academic scientists and companies developing clinical candidates. Collaborations also provides machine learning expertise and software to consumer product and agrochemical companies. | Location Raleigh |
| |
Company Cosette Pharmaceuticals | Activity: Production and Manufacturing | Company Description Cosette Pharmaceuticals manufactures OTC and prescription hydrocortisone, antifungal and permethrin products such as creams, ointments, liquids and suppositories. | Location Lincolnton |
| |
Company Countervail Corp. | Activity: Research and Development | Company Description Countervail is developing proprietary drug and diagnostic technologies to detect exposure to and prevent adverse effects from organophosphate pesticides. | Location Mint Hill |
| |
Company Couragen Biopharmaceutics LLC | Activity: Research and Development | Company Description Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research. | Location Chapel Hill |
| |
Company Creyon Bio | Activity: Research and Development | Company Description Creyon Bio is a drug development company engineering RNA-based medicines and their components. | Location Research Triangle Park |
| |
Company CSL Seqirus | Activity: Production and Manufacturing | Company Description Seqirus manufactures influenza vaccines using both egg-based and cell-based technologies. | Location Holly Springs |
| |
Company Dechra Pharmaceuticals | Activity: Research and Development | Company Description Dechra Pharmaceuticals develops veterinary pharmaceuticals with a focus on major companion animal categories. | Location Greensboro |
| |
Company DelAQUA Pharmaceuticals Inc. | Activity: Research and Development | Company Description DelAQUA Pharmaceuticals is developing technology to enhance the solubility and stability of drugs and drug candidates and to improve their efficacy and safety. | Location Chapel Hill |
| |
Company Denizen Biologics LLC | Activity: Research and Development | Company Description Denizen Biologics develops gene therapy vectors to enhance the capability of genetic medicine and improve the outcomes for patients. | Location Cary |
| |
Company Dermavant Sciences | Activity: Research and Development | Company Description Dermavant, a part of the Roivant family of companies, develops therapies for the treatment of skin diseases. | Location Morrisville |
| |
Company Dignify Therapeutics LLC | Activity: Research and Development | Company Description Dignify Therapeutics develops novel bowel and bladder therapies for people with neurological disorders and the elderly that suffer from incontinence. | Location Research Triangle Park |
| |
Company Doron Therapeutics | Activity: Research and Development | Company Description Doron Therapeutics is developing an injectable biologic to treat osteoarthritis and other musculoskeletal diseases. | Location Chapel Hill |
| |
Company DotBio LLC | Activity: Research and Development | Company Description DotBio develops immuno-oncology therapies. | Location Weddington |
| |
Company Drive Therapeutics LLC | Activity: Research and Development | Company Description Drive Therapeutics is developing therapeutics for wet age-related macular degeneration (wAMD) and diabetic retinopathy/diabetic macular edema (DR/DME). | Location Research Triangle Park |